Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 µM) and between 10%-20% (0.1 µM). Pariceract can be used for Parkinsons disease and endometriosis research[1].
Molecular Weight:
358.48
Purity:
99.11
CAS Number:
[1919820-28-2]
Formula:
C20H30N4O2
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
